Keyphrases
Nicotinic Acetylcholine Receptor (nAChR)
100%
Dopamine Release
100%
Nicotine
100%
Agonism
100%
Varenicline
100%
Occupancy
33%
Raclopride
33%
Ventral Striatum
33%
Placebo
22%
Cigarette Smoking
22%
Cigarette
22%
Behavioral Measures
22%
Nicotinic Receptors
22%
Nicotine Withdrawal
22%
Partial Agonist
22%
Brain Regions
11%
Therapeutic Implications
11%
Placebo Groups
11%
Twice Daily
11%
Positron Emission Tomography
11%
Putamen
11%
Receptor Blockade
11%
Mesolimbic
11%
Dopamine System
11%
Receptor Binding
11%
Smokers
11%
Non-specific Binding
11%
Midbrain
11%
Smoking Cessation
11%
Human Studies
11%
Significant Relationship
11%
Dopamine Receptor
11%
Nicotine Use
11%
Binding Potential
11%
Human Laboratory
11%
Smoking Quit Attempt
11%
Placebo-controlled Study
11%
Daily Smokers
11%
Smoking Cessation Intervention
11%
First-time-in-human
11%
Placebo Effect
11%
Nicotine Craving
11%
Mechanistic Implication
11%
Behavioral Causes
11%
Quit Rate
11%
Agonist Drugs
11%
Neuroscience
Nicotinic Acetylcholine Receptor
100%
Dopamine Release
100%
Varenicline
100%
Placebo
55%
Raclopride
33%
Fluorine-18
33%
Ventral Striatum
33%
Thalamus
22%
Nicotinic Receptor
22%
Positron Emission Tomography
11%
Putamen
11%
Receptor Binding
11%
Agonist
11%
Midbrain
11%
Dopamine Receptor
11%
Receptor Partial Agonist
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinic Receptor
100%
Varenicline
100%
Placebo
44%
Raclopride
33%
Fluorine 18
33%
Carbon 11
22%
Cigarette Smoking
22%
Partial Agonist
22%
Dopamine Receptor
11%
Human Study
11%
Binding Potential
11%
Placebo-Controlled Study
11%